About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Boston | 459 Studies

Clinical Trials Prostate CancerBoston

Prostate Cancer Clinical Trials in Boston

Find 459 clinical trials for prostate cancer near Boston, Massachusetts. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Boston

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 261-280 of 459 trials

RecruitingA Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate CancerThis is a Phase 1b, multi-center, open-label study to evaluate the safety, tolerability, dosimetry, and pharmacokinetics (PK) of \[64Cu\]Cu-AKY-2519 and/or \[225Ac\]Ac-AKY-2519…NCT07581184·Irvine, California and 7 others RecruitingA Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerThis study is being conducted to learn more about the safety, tolerability, and effectiveness of an experimental treatment for metastatic prostate cancer called AZD6621.NCT07192614·Orlando, Florida and 25 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

WithdrawnShared Decision Making in Low Risk Prostate CancerThis study will evaluate the usefulness of an informational website designed to educate patients with prostate cancer about their options for treatment.NCT01673581·Boston, Massachusetts

CompletedWhole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate CancerThis phase 0 trial studies whole body fluorine F 18 sodium fluoride positron emission tomography (PET)/computed tomography (CT) scan and whole body magnetic resonance imaging…NCT00956163·Boston, Massachusetts

CompletedCrizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate CancerThis research study is comparing the combination of drugs Crizotinib and Enzalutamide as a possible treatment for metastatic castration-resistant prostate cancer (mCRPC).NCT02207504·Boston, Massachusetts

CompletedTIPOPS (Telemedicine vs In Person Oncology Patient Surveillance)This research study is comparing telemedicine and face-to-face visits to understand patients' experiences with telemedicine versus face to face visits and to understand when it is…NCT04936243·Boston, Massachusetts and 1 other

TerminatedA Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCThe purpose of this study is to compare galeterone to enzalutamide in men expressing androgen receptor spice variant-7 mRNA (AR-V7) in metastatic (M1) castrate resistant prostate…NCT02438007·Scottsdale, Arizona and 116 others

Active not recruitingPhase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or second androgen receptor-directed…NCT06691984·Birmingham, Alabama and 163 others

CompletedLow, Intermediate, or High Dose Suramin in Treating Patients With Hormone-Refractory Prostate CancerRandomized phase III trial to compare the effectiveness of low, intermediate, and high dose suramin in treating men with stage IV prostate cancer that is refractory to hormone…NCT00002723·Chicago, Illinois and 26 others

CompletedDocetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone MetastasesRATIONALE: Drugs used in chemotherapy, such as docetaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00080678·Boston, Massachusetts and 2 others

TerminatedStudy of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsAt the time of study termination, NUV-422-02 was a first-in-human, open-label, Phase 1 dose escalation study designed to evaluate the safety and efficacy of NUV-422.NCT04541225·Tucson, Arizona and 11 others

CompletedA Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid TumorsThis is a first-in-human, open-label, dose escalation study to evaluate the safety and tolerability of pegilodecakin in participants with advanced solid tumors, dosed daily…NCT02009449·Los Angeles, California and 9 others

CompletedMGD019 DART® Protein in Unresectable/Metastatic CancerThe purpose of this study is to evaluate the safety and tolerability, pharmacokinetics (PK) pharmacodynamics and preliminary antitumor activity of lorigerlimab.NCT03761017·Chicago, Illinois and 38 others

Active not recruitingStudy of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesThis research is designed to determine if experimental treatment with PARP inhibitor, AZD5305, alone, or in combination with anti-cancer agents is safe, tolerable, and has…NCT04644068·Boston, Massachusetts and 67 others

Active not recruitingStereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate CancerThis randomized phase III trial studies how well stereotactic body radiation therapy works compared to intensity-modulated radiation therapy in treating patients with stage IIA-B…NCT03367702·Mobile, Alabama and 292 others

Active not recruitingVeterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerThis is a prospective, open-label, multi-center seamless phase II to phase III randomized clinical trial designed to compare SST with or without PET-directed local therapy in…NCT04787744·Long Beach, California and 19 others

CompletedAndrogen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate CancerThis phase II trial studies how well androgen deprivation therapy and vorinostat followed by radical prostatectomy works in treating patients with prostate cancer that has not…NCT00589472·Los Angeles, California and 14 others

CompletedVaccine Therapy in Treating Patients With Metastatic Prostate CancerPhase I trial to study the effectiveness of vaccine therapy in treating patients with metastatic prostate cancer.NCT00004029·Boston, Massachusetts and 2 others

RecruitingAndrogen-responsive POSLUMA-guided Intra-prostatic BoostThis research study is for men with intermediate- or high-risk prostate cancer who are planning to receive hormone therapy and radiation treatment.NCT07393867·Boston, Massachusetts and 3 others

Active not recruitingPSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate CancerThe goal of this clinical trial is to learn if serial PSMA-PET/CT scans can be used to monitor response to therapy in metastatic hormone sensitive prostate cancer and can be…NCT06479187·Boston, Massachusetts and 1 other

PreviousPage 14 of 23Next

Other Conditions in Boston

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma